https://news.medxy.ai/zh/%e6%97%a2%e5%be%80%e7%9d%ab%e7%8a%b6%e4%bd%93%e5%b9%b3%e5%9d%a6%e9%83%a8%e7%8e%bb%e7%92%83%e4%bd%93%e5%88%87%e9%99%a4%e6%9c%af%e6%82%a3%e8%80%85%e7%99%bd%e5%86%85%e9%9a%9c%e6%89%8b%e6%9c%af%e5%90%8e/Medxy AIzh2026-08-02T11:59:24-07:00既往睫状体平坦部玻璃体切除术患者白内障手术后人工晶状体眼囊样黄斑水肿风险升高：大型回顾性队列研究提示 https://news.medxy.ai/ja/%e7%99%bd%e5%86%85%e9%9a%9c%e6%89%8b%e8%a1%93%e5%be%8c%e3%81%ae%e5%81%bd%e6%b0%b4%e6%99%b6%e4%bd%93%e9%bb%84%e6%96%91%e6%b5%ae%e8%85%ab%e3%83%aa%e3%82%b9%e3%82%af%e3%81%af%e3%80%81%e6%97%a2%e5%be%80-p/Medxy AIja2026-08-02T11:59:08-07:00白内障手術後の偽水晶体黄斑浮腫リスクは、既往 pars plana vitrectomy 眼で上昇する：大規模後ろ向きコホート研究からの知見 https://news.medxy.ai/vi/60766-2/Medxy AIvi2026-08-02T11:58:49-07:00 https://news.medxy.ai/increased-risk-of-pseudophakic-cystoid-macular-edema-after-cataract-surgery-in-eyes-with-prior-pars-plana-vitrectomy-insights-from-a-large-retrospective-cohort-study/Medxy AIen2026-08-02T11:58:07-07:00Increased Risk of Pseudophakic Cystoid Macular Edema After Cataract Surgery in Eyes with Prior Pars Plana Vitrectomy: Insights from a Large Retrospective Cohort Study https://news.medxy.ai/zh/one-year-success-in-endothelial-keratoplasty/Medxy AIzh2026-08-02T11:56:58-07:00DMEK术后1年成功的决定因素：来自糖尿病内皮角膜移植研究的启示 https://news.medxy.ai/ja/one-year-success-in-descemet-membrane-endothelial-keratoplasty/Medxy AIja2026-08-02T11:56:42-07:00Descemet膜内皮角膜移植術の1年成功を左右する因子：Diabetes Endothelial Keratoplasty Studyからの知見 https://news.medxy.ai/vi/one-year-success-in-descemet-membrane-endothelial-keratoplasty-insights-from-the-diabetes-endothelial-keratoplasty-study/Medxy AIvi2026-08-02T11:56:24-07:00Những yếu tố quyết định thành công sau 1 năm của ghép nội mô màng Descemet: Góc nhìn từ Diabetes Endothelial Keratoplasty Study https://news.medxy.ai/determinants-of-one-year-success-in-descemet-membrane-endothelial-keratoplasty-insights-from-the-diabetes-endothelial-keratoplasty-study/Medxy AIen2026-08-02T11:55:41-07:00Determinants of One-Year Success in Descemet Membrane Endothelial Keratoplasty: Insights from the Diabetes Endothelial Keratoplasty Study https://news.medxy.ai/zh/patient-perceptions-of-telehealth-in-head-and-neck-cancer-surveillance/Medxy AIzh2026-08-02T11:51:39-07:00头颈癌随访中的远程医疗：患者如何看待它？一项定性综合 https://news.medxy.ai/vi/patient-perceptions-of-telehealth-use-in-head-and-neck-cancer-surveillance/Medxy AIvi2026-08-02T11:50:54-07:00Người bệnh nhìn nhận telehealth ra sao trong theo dõi ung thư đầu và cổ? Tổng hợp định tính https://news.medxy.ai/patient-perceptions-of-telehealth-use-in-head-and-neck-cancer-surveillance-a-qualitative-synthesis/Medxy AIen2026-08-02T11:49:48-07:00Patient Perceptions of Telehealth Use in Head and Neck Cancer Surveillance: A Qualitative Synthesis https://news.medxy.ai/zh/disparities-in-otolaryngologist-availability-versus-patient-demand-in-the-u-s/Medxy AIzh2026-08-02T11:41:16-07:00供需错位：美国耳鼻咽喉科医生可及性与患者需求的地理差异 https://news.medxy.ai/vi/geographic-disparities-in-otolaryngologist-availability-versus-patient-demand-in-the-u-s/Medxy AIvi2026-08-02T11:40:27-07:00Bản đồ khoảng cách: Chênh lệch địa lý giữa nguồn cung bác sĩ Tai mũi họng và nhu cầu người bệnh tại Hoa Kỳ https://news.medxy.ai/mapping-the-gap-geographic-disparities-in-otolaryngologist-availability-versus-patient-demand-in-the-u-s/Medxy AIen2026-08-02T11:39:50-07:00Mapping the Gap: Geographic Disparities in Otolaryngologist Availability Versus Patient Demand in the U.S. https://news.medxy.ai/zh/colectomy-for-cancer-risk-factors-associations-and-outcomes/Medxy AIzh2026-08-02T11:39:23-07:00结直肠癌择期结肠切除术后急性结肠缺血：风险因素、手术关联与结局 https://news.medxy.ai/ja/colectomy-for-cancer-risk-factors-procedural-associations-and-outcomes/Medxy AIja2026-08-02T11:39:06-07:00がんに対する待機的結腸切除術後の急性大腸虚血：危険因子、術式関連性、転帰 https://news.medxy.ai/vi/elective-colectomy-for-cancer-risk-factors-procedural-associations-and-outcomes/Medxy AIvi2026-08-02T11:38:42-07:00Thiếu máu cục bộ đại tràng cấp tính sau cắt đại tràng chủ động vì ung thư: Yếu tố nguy cơ, mối liên quan với thủ thuật và kết cục https://news.medxy.ai/acute-colonic-ischemia-following-elective-colectomy-for-cancer-risk-factors-procedural-associations-and-outcomes/Medxy AIen2026-08-02T11:37:42-07:00Acute Colonic Ischemia Following Elective Colectomy for Cancer: Risk Factors, Procedural Associations, and Outcomes https://news.medxy.ai/zh/locally-advanced-pancreatic-cancer-hypofractionated-ablative-radiation-therapy/Medxy AIzh2026-08-02T11:35:54-07:00大分割消融放疗为局部晚期胰腺癌争取切除机会与生存获益 https://news.medxy.ai/ja/locally-advanced-pancreatic-cancer-with-hypofractionated-ablative-radiation-therapy/Medxy AIja2026-08-02T11:35:38-07:00低分割高線量放射線療法で切除不能局所進行膵癌の治療成績を高める https://news.medxy.ai/vi/outcomes-in-locally-advanced-pancreatic-cancer-with-hypofractionated-ablative-radiation-therapy/Medxy AIvi2026-08-02T11:35:21-07:00Xạ trị gây hủy diệt khối u phân liều cao: hướng đi triển vọng cho ung thư tụy tiến triển tại chỗ https://news.medxy.ai/maximizing-outcomes-in-locally-advanced-pancreatic-cancer-with-hypofractionated-ablative-radiation-therapy/Medxy AIen2026-08-02T11:34:39-07:00Maximizing Outcomes in Locally Advanced Pancreatic Cancer with Hypofractionated Ablative Radiation Therapy https://news.medxy.ai/zh/burn-injury-immune-activation-neuroinflammation/Medxy AIzh2026-08-02T11:33:36-07:00烧伤如何重塑细胞外囊泡通讯：连接免疫激活与神经炎症 https://news.medxy.ai/ja/burn-injury-immune-activation-and-neuroinflammation/Medxy AIja2026-08-02T11:33:21-07:00熱傷が細胞外小胞の通信機構を再編する：免疫活性化と神経炎症を結び付ける https://news.medxy.ai/vi/burn-injury-linking-immune-activation-and-neuroinflammation/Medxy AIvi2026-08-02T11:33:03-07:00Bỏng nặng làm tái lập trình giao tiếp của túi ngoại bào: Cầu nối giữa hoạt hóa miễn dịch và viêm thần kinh https://news.medxy.ai/burn-injury-reprograms-extracellular-vesicle-communication-linking-immune-activation-and-neuroinflammation/Medxy AIen2026-08-02T11:32:23-07:00Burn Injury Reprograms Extracellular Vesicle Communication: Linking Immune Activation and Neuroinflammation https://news.medxy.ai/zh/mlh1-promoter-hypermethylation-not-impact-survival-outcomes-in-dmmr-endometrial-cancer/Medxy AIzh2026-08-01T09:53:38-07:00MLH1 启动子高甲基化不影响 dMMR 子宫内膜癌接受免疫检查点抑制剂治疗的生存结局 https://news.medxy.ai/ja/mlh1-promoter-hypermethylation-does-not-impact-survival-outcomes-in-dmmr-endometrial-cancer/Medxy AIja2026-08-01T09:53:21-07:00MLH1プロモーター高メチル化は、dMMR子宮内膜癌における免疫チェックポイント阻害療法後の生存に影響しない https://news.medxy.ai/vi/mlh1-promoter-hypermethylation-does-not-impact-survival-outcomes-in-dmmr-endometrial-cancer-with-immune-checkpoint-inhibitors/Medxy AIvi2026-08-01T09:53:03-07:00Tăng methyl hóa promoter MLH1 không làm thay đổi tiên lượng sống còn ở ung thư nội mạc tử cung dMMR điều trị bằng thuốc ức chế điểm kiểm soát miễn dịch https://news.medxy.ai/mlh1-promoter-hypermethylation-does-not-impact-survival-outcomes-in-dmmr-endometrial-cancer-treated-with-immune-checkpoint-inhibitors/Medxy AIen2026-08-01T09:51:47-07:00MLH1 Promoter Hypermethylation Does Not Impact Survival Outcomes in dMMR Endometrial Cancer Treated with Immune Checkpoint Inhibitors https://news.medxy.ai/zh/medical-mistrust-and-patient-in-obgyn-care/Medxy AIzh2026-08-01T08:18:56-07:00弥合信任鸿沟：解读妇产科诊疗中的医疗不信任与患者体验 https://news.medxy.ai/ja/medical-mistrust-and-patient-in-ob-gyn-care/Medxy AIja2026-08-01T08:18:41-07:00OB/GYN診療における医療不信と患者体験を読み解く：分断をつなぐ視点 https://news.medxy.ai/vi/bridging-the-gap-understanding-medical-mistrust-and-patient-in-ob-gyn-care/Medxy AIvi2026-08-01T08:18:22-07:00Thu hẹp khoảng cách: Hiểu về ngờ vực y khoa và trải nghiệm của người bệnh trong chăm sóc OB/GYN https://news.medxy.ai/bridging-the-gap-understanding-medical-mistrust-and-patient-experiences-in-ob-gyn-care/Medxy AIen2026-08-01T08:16:21-07:00Bridging the Gap: Understanding Medical Mistrust and Patient Experiences in OB/GYN Care https://news.medxy.ai/zh/placenta-accreta-spectrum-a-topography-guided-approach-to-prenatal-imaging-and-surgical-management/Medxy AIzh2026-07-31T15:01:57-07:00重新审视胎盘植入谱系：基于拓扑分布的产前影像评估与个体化手术管理 https://news.medxy.ai/ja/placenta-accreta-spectrum-a-topography-guided-to-prenatal-imaging-and-tailored-surgical-management/Medxy AIja2026-07-31T15:01:40-07:00癒着胎盤スペクトラムを再考する：出生前画像診断と個別化手術管理へのトポグラフィー主導アプローチ https://news.medxy.ai/vi/placenta-accreta-spectrum-a-topography-guided-approach-to-prenatal-imaging-and-tailored-surgical-management/Medxy AIvi2026-07-31T15:01:20-07:00Nhìn lại hội chứng nhau cài răng lược: Tiếp cận theo địa hình để chẩn đoán hình ảnh trước sinh và xử trí phẫu thuật cá thể hóa https://news.medxy.ai/rethinking-placenta-accreta-spectrum-a-topography-guided-approach-to-prenatal-imaging-and-tailored-surgical-management/Medxy AIen2026-07-31T15:00:32-07:00Rethinking Placenta Accreta Spectrum: A Topography-Guided Approach to Prenatal Imaging and Tailored Surgical Management https://news.medxy.ai/zh/disparities-and-persistence-in-systemic-hormone-therapy-in-menopausal-women/Medxy AIzh2026-07-31T14:17:36-07:00绝经女性全身性激素治疗的差异与持续性：来自大规模真实世界分析的启示 https://news.medxy.ai/vi/disparities-and-persistence-in-systemic-hormone-therapy-among-menopausal-women/Medxy AIvi2026-07-31T14:16:50-07:00Chênh lệch và mức độ duy trì liệu pháp hormone toàn thân ở phụ nữ mãn kinh: Góc nhìn từ một phân tích thực tế quy mô lớn https://news.medxy.ai/disparities-and-persistence-in-systemic-hormone-therapy-among-menopausal-women-insights-from-a-large-real-world-analysis/Medxy AIen2026-07-31T14:16:04-07:00Disparities and Persistence in Systemic Hormone Therapy Among Menopausal Women: Insights from a Large Real-World Analysis https://news.medxy.ai/zh/ripply1-in-ctnnb1-mutated-hepatocellular-carcinoma/Medxy AIzh2026-07-31T13:35:27-07:00RIPPLY1：CTNNB1突变型肝细胞癌中的“守护者” https://news.medxy.ai/ja/ripply1-against-cancer-in-ctnnb1-mutated-hepatocellular-carcinoma/Medxy AIja2026-07-31T13:35:05-07:00CTNNB1変異肝細胞癌におけるがん幹細胞性の抑制因子RIPPLY1の役割 https://news.medxy.ai/vi/ripply1-against-cancer-stemness-in-ctnnb1-mutated-hepatocellular-carcinoma/Medxy AIvi2026-07-31T13:34:43-07:00RIPPLY1: “lá chắn” chống tính chất tế bào gốc ung thư trong ung thư biểu mô tế bào gan mang đột biến CTNNB1 https://news.medxy.ai/ripply1-as-a-guardian-against-cancer-stemness-in-ctnnb1-mutated-hepatocellular-carcinoma/Medxy AIen2026-07-31T13:33:47-07:00RIPPLY1 as a Guardian Against Cancer Stemness in CTNNB1-Mutated Hepatocellular Carcinoma https://news.medxy.ai/zh/masld-sex-specific-endotypes-and-mortality/Medxy AIzh2026-07-31T13:14:33-07:00蛋白组学揭示MASLD：性别特异性内表型及其死亡预测价值 https://news.medxy.ai/ja/masld-sex-specific-endotypes-and-predictive-for-mortality/Medxy AIja2026-07-31T13:14:14-07:00MASLDのプロテオーム解析が解き明かす性差エンドタイプと死亡予測能 https://news.medxy.ai/vi/masld-sex-specific-endotypes-and-predictive-value-for-mortality/Medxy AIvi2026-07-31T13:13:52-07:00Proteomics hé lộ MASLD: các endotype đặc hiệu theo giới và giá trị dự báo tử vong https://news.medxy.ai/proteomic-insights-into-masld-sex-specific-endotypes-and-predictive-value-for-mortality/Medxy AIen2026-07-31T13:13:02-07:00Proteomic Insights into MASLD: Sex-Specific Endotypes and Predictive Value for Mortality https://news.medxy.ai/zh/colorectal-cancer-prognostication-validating-enhanced-ai-for-risk-stratification/Medxy AIzh2026-07-31T13:11:55-07:00AI 赋能 II 期结直肠癌预后评估：语义增强模型助力风险分层优化 https://news.medxy.ai/ja/colorectal-cancer-prognostication-validating-semantically-enhanced-ai-for-risk-stratification/Medxy AIja2026-07-31T13:11:34-07:00stage II大腸癌の予後予測を変える：意味論的強化AIによるリスク層別化の検証 https://news.medxy.ai/vi/stage-ii-colorectal-cancer-prognostication-validating-semantically-enhanced-ai-for-risk-stratification/Medxy AIvi2026-07-31T13:11:11-07:00Tái định hình tiên lượng ung thư đại trực tràng giai đoạn II: Thẩm định AI tăng cường ngữ nghĩa cho phân tầng nguy cơ https://news.medxy.ai/revolutionizing-stage-ii-colorectal-cancer-prognostication-validating-semantically-enhanced-ai-for-risk-stratification/Medxy AIen2026-07-31T13:10:24-07:00Revolutionizing Stage II Colorectal Cancer Prognostication: Validating Semantically-Enhanced AI for Risk Stratification https://news.medxy.ai/zh/blood-pressure-endovascular-thrombectomy-risks-of-acute-kidney-injury/Medxy AIzh2026-07-31T13:03:10-07:00血管内取栓术后血压如何平衡：急性肾损伤风险与卒中康复结局 https://news.medxy.ai/ja/blood-pressure-after-endovascular-thrombectomy-risks-of-acute-kidney-injury/Medxy AIja2026-07-31T13:02:53-07:00経血管的血栓除去術後の血圧管理：急性腎障害リスクと脳卒中回復への影響 https://news.medxy.ai/vi/blood-pressure-after-endovascular-thrombectomy-risks-of-acute-kidney-injury-and-impact-on-stroke-recovery/Medxy AIvi2026-07-31T13:02:34-07:00Cân bằng huyết áp sau lấy huyết khối nội mạch: nguy cơ tổn thương thận cấp và ảnh hưởng đến hồi phục sau đột quỵ https://news.medxy.ai/balancing-blood-pressure-after-endovascular-thrombectomy-risks-of-acute-kidney-injury-and-impact-on-stroke-recovery/Medxy AIen2026-07-31T13:01:36-07:00Balancing Blood Pressure After Endovascular Thrombectomy: Risks of Acute Kidney Injury and Impact on Stroke Recovery https://news.medxy.ai/zh/decoding-sleeps-role-in-cognitive-health-and-dementia-risk/Medxy AIzh2026-07-31T12:58:48-07:00解析睡眠在认知健康与痴呆风险中的作用：来自睡眠与痴呆联盟的研究见解 https://news.medxy.ai/decoding-sleeps-role-in-cognitive-health-and-dementia-risk-insights-from-the-sleep-and-dementia-consortium/Medxy AIen2026-07-31T12:57:20-07:00Decoding Sleep’s Role in Cognitive Health and Dementia Risk: Insights from the Sleep and Dementia Consortium https://news.medxy.ai/zh/pemetrexed-monotherapy-and-combination-with-carboplatin-in-advanced-thyroid-cancer/Medxy AIzh2026-07-31T12:56:08-07:00晚期甲状腺癌中培美曲塞单药及联合卡铂治疗的疗效评估：一项回顾性队列分析 https://news.medxy.ai/ja/pemetrexed-monotherapy-and-combination-therapy-with-carboplatin-in-advanced-thyroid-cancer/Medxy AIja2026-07-31T12:55:53-07:00進行性甲状腺癌に対するpemetrexed単剤療法とcarboplatin併用療法の評価：後ろ向きコホート解析 https://news.medxy.ai/vi/pemetrexed-monotherapy-and-combination-therapy-with-carboplatin-in-advanced-thyroid-cancer-a-retrospective-cohort-analysis/Medxy AIvi2026-07-31T12:55:34-07:00Đánh giá pemetrexed đơn trị và phối hợp carboplatin trong ung thư tuyến giáp tiến triển: phân tích đoàn hệ hồi cứu https://news.medxy.ai/evaluating-pemetrexed-monotherapy-and-combination-therapy-with-carboplatin-in-advanced-thyroid-cancer-a-retrospective-cohort-analysis/Medxy AIen2026-07-31T12:54:35-07:00Evaluating Pemetrexed Monotherapy and Combination Therapy with Carboplatin in Advanced Thyroid Cancer: A Retrospective Cohort Analysis https://news.medxy.ai/ja/dapagliflozin-and-lipoprotein-metabolism-in-t2dm-preserving-ldl-catabolism-and-vldl-processing/Medxy AIja2026-07-31T12:53:41-07:00ダパグリフロジンは2型糖尿病の脂質代謝をどう変えるか：LDL分解を保ちつつVLDL処理を正常化する https://news.medxy.ai/vi/dapagliflozin-and-lipoprotein-metabolism-in-t2dm-preserving-ldl-catabolism-and-normalizing-vldl-processing/Medxy AIvi2026-07-31T12:53:18-07:00Dapagliflozin và chuyển hóa lipoprotein trong đái tháo đường type 2: bảo tồn dị hóa LDL và đưa xử lý VLDL về gần sinh lý bình thường https://news.medxy.ai/dapagliflozin-and-lipoprotein-metabolism-in-type-2-diabetes-preserving-ldl-catabolism-and-normalizing-vldl-processing/Medxy AIen2026-07-31T12:52:26-07:00Dapagliflozin and Lipoprotein Metabolism in Type 2 Diabetes: Preserving LDL Catabolism and Normalizing VLDL Processing